Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Jazz Acquires Actio Bioscience

Pharmaceutical Executive Daily: Jazz Acquires Actio Bioscience

Published 3 months, 1 week ago
Description
In today's Pharmaceutical Executive Daily, Jazz Pharmaceuticals agrees to acquire Actio Biosciences, Novo Nordisk, Innate Pharma, and Innovent Biologics strike a trio of new partnerships, and a Veeva executive discusses how agentic AI is surfacing HCP insights that traditional field reporting has historically missed.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us